Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XREF LIMITED Interim / Quarterly Report 2018

Apr 29, 2018

66097_rns_2018-04-29_5422eb8f-b94a-46d8-9bbe-d148a76f25df.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

DRAFT

Appendix 4C

==> picture [147 x 34] intentionally omitted <==

Quarterly report for entities subject to Listing Rule 4.7B

Name of entity
Xref Limited
ACN
122 404 666
Consolidated statement of cash flows
Quarterended ("current quarter")
31 March 18
1
Cash flows from operating activities
1.1
Receipts from customers
1.2
Payments for
(a)
research and development
(b)
product manufacturing and operating costs
(c)
advertising and marketing
(d)
leased assets
(e)
staff costs
(f)
administration and corporate costs
1.3
Dividends received
1.4
Interest received
1.5
Interest and other costs of finance paid
1.6
Income taxes paid
1.7
Government grants and tax incentives
1.8
Other (provide details if material)
- GST on sales for the period
- Net foreign exchange gain
1.9
Net cash from / (used in) operating activities
Current
quarter
$A'000
1,587
(11)
(84)
(364)
(201)
(2,318)
(529)
30
164
74
Year to date
(9 months)
$A'000
4,393
(311)
(339)
(1,258)
(605)
(7,041)
(1,714)
96
1,385
456
26
(1,652) (4,912)
2
Cash flows from investing activities
2.1
Payments to acquire
(a)
property, plant and equipment
(b)
businesses (item 10)
(c)
investments
(d)
intellectual property
(e)
other non-current assets
2.2
Proceeds from disposal of:
(a)
property, plant and equipment
(b)
businesses (item 10)
(c)
investments
(d)
intellectual property
(e)
other non-current assets
2.3
Cash flows from loans to other entities
2.4
Dividends received (see note 3)
2.5
Other (provide details if material) -
2.6
Net cash from / (used in) investing activities
(89)
-
-
-
-
-
-
-
-
-
-
-
-
(187)
-
-
-
-
-
-
-
-
-
-
-
-
(89) (187)

Xref Limited

Page 1 of 3

Appendix 4C - 31 March 2018

3
3.1
3.2
3.3
Proceeds from exercise of share options
3.4
3.5
Proceeds from borrowings
3.6
Repayment of borrowings
3.7
3.8
Dividends paid
3.9
Other (provide details if material)
3.10
Net cash from / (used in) financing activities
Cash flows from financing activities
Proceeds from issues of shares
Proceeds from issue of convertible notes
Transaction costs related to issues of shares, convertible
notes or options
Transaction costs related to loans and borrowings
Current
quarter
$A'000
-
-
-
-
-
-
Year to date
(9 months)
$A'000
7,500
(484)
-
-
-
-
- 7,016
4
4.1
4.2
4.3
4.4
4.5
Effect of movement in exchange rates on cash held
4.6
Cash and cash equivalents at end of quarter
Net increase (decrease) in cash and cash equivalents
for the period held
Cash and cash equivalents at beginning of
quarter /year to date
Net cash from / (used in) operating activities
(item 1.9 above)
Net cash from / (used in) investing activities
(item 2.6 above)
Net cash from / (used in) financing activities
(item 3.10 above)
Current
quarter
$A'000
7,726
(1,652)
(89)
-
(93)


Year to date
(9 months)
$A'000
4,111
(4,912)
(187)
7,016
(136)
5,892 5,892
5
Reconciliation of cash and cash equivalents
5.1
Bank balances
5.2
Call deposits
5.3
Bank overdrafts
5.4
Other (provide details)
5.5
Cash and cash equivalents at end of quarter
at the end of the quarter (as shown in the consolidated
statement of cash flows) to the related items in the
accounts
Current
quarter
$A'000
5,821
71
-
-
Previous
quarter
$A'000
7,655
71
-
-
5,892 7,726
6
6.1
6.2
Payments to directors of the entity and
associates of the directors
Aggregate amount of payments to these parties included
in item 1.2
Aggregate amount of cash flow from loans to these parties
included in item 2.3
Current
quarter
$A'000
206
Current
quarter
$A'000
206
6.3
Include below any explanation necessary to understand
the transactions included in items 6.1 and 6.2

Xref Limited

Page 2 of 3

Appendix 4C - 31 March 2018

  • 7 Payments to related entities of the entity and Current associates of the related entities quarter $A'000

  • 7.1 Aggregate amount of payments to these parties included 90

  • in item 1.2

  • 7.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 - 7.3 Include below any explanation necessary to understand the transactions included in 7.1 and 7.2

8 Financing facilities available


8.1
Loan facilities
8.2
Credit standby arrangements
8.3
Other (please specify)
Add notes as necessary for an understanding of
the position.
Total facility
amount at
quarter end
$A'000
-
-
-
Amount drawn at
quarter end
$A'000
-
-
-
8.4
Include below a description of each facility above, including the lender, interest rate and whether it
is secured or unsecured. If any additional facilities have been entered into or are proposed to be
entered into after quarter end, include details of those facilities as well.
  • 8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.
9
Estimated cash outflows for next quarter
9.1
Research and Development
9.2
Product manufacturing and operating costs
9.3
Advertising and marketing
9.4
Leased assets
9.5
Staff costs
9.6
Administration and corporate costs
9.7
Other (provide details if material)
9.8
Total estimated cash outflows
10
10.1
Name of entity
10.2
Place of incorporation or registration
10.3
Consideration for acquisition or disposal
10.4
Total net assets
10.5
Nature of business
Acquisitions and disposals of business
$A'000
15
82
356
221
2,445
386
$A'000
15
82
356
221
2,445
386
3,505
Acquisitions Disposals
n/a n/a

Compliance statement

  • 1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

  • 2 This statement does give a true and fair view of the matters disclosed.

Sign here:

==> picture [88 x 41] intentionally omitted <==

Print name: James Solomons, CFO

Date: 30 April 2018

Xref Limited

Page 3 of 3

Appendix 4C - 31 March 2018